ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 37 filers reported holding ARGOS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,000 | -50.0% | 11,900 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | -50.0% | 11,900 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | -95.1% | 11,900 | -93.5% | 0.00% | – |
| Q1 2017 | $82,000 | -90.6% | 184,194 | +3.8% | 0.00% | – |
| Q4 2016 | $870,000 | +10.5% | 177,494 | +11.7% | 0.00% | – |
| Q3 2016 | $787,000 | +6.2% | 158,869 | +31.3% | 0.00% | – |
| Q2 2016 | $741,000 | +179.6% | 120,996 | +356.5% | 0.00% | – |
| Q1 2014 | $265,000 | – | 26,507 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 13,242,279 | $64,887,000 | 55.88% |
| Pharmstandard International S.A. | 5,120,604 | $27,390,000 | 23.59% |
| SANDERS MORRIS HARRIS LLC | 292,512 | $1,433,000 | 0.66% |
| WALL STREET ASSOCIATES | 82,850 | $406,000 | 0.27% |
| WASATCH ADVISORS LP | 3,254,211 | $15,946,000 | 0.24% |
| ALTRINSIC GLOBAL ADVISORS LLC | 172,505 | $845,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 121,524 | $595,000 | 0.01% |
| Alyeska Investment Group, L.P. | 200,000 | $980,000 | 0.01% |
| Acrospire Investment Management LLC | 1,800 | $9,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,024,428 | $5,020,000 | 0.00% |